{
    "Trade/Device Name(s)": [
        "ARCHITECT Cyclosporine Assay",
        "ARCHITECT Cyclosporine Calibrators"
    ],
    "Submitter Information": "Fujirebio Diagnostics, Inc.",
    "510(k) Number": "K080751",
    "Predicate Device Reference 510(k) Number(s)": [
        "P890025"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MKW",
        "DLJ"
    ],
    "Summary Letter Date": "August 25, 2008",
    "Summary Letter Received Date": "August 26, 2008",
    "Submission Date": "March 10, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.1235",
        "21 CFR 862.3200"
    ],
    "Regulation Name(s)": [
        "Cyclosporine Test System"
    ],
    "Analyte Class(es)": [
        "transplant",
        "tdm",
        "toxicology"
    ],
    "Analyte(s)": [
        "Cyclosporine"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "EDTA Whole Blood Collection Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent Microparticle Immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT Cyclosporine Assay and Calibrators for quantitative measurement of cyclosporine in whole blood using CMIA technology on the ARCHITECT i System.",
    "Indications for Use Summary": "Quantitative determination of cyclosporine in human whole blood on the ARCHITECT i System as an aid in the management of heart, liver, and kidney transplant patients receiving cyclosporine therapy.",
    "fda_folder": "Clinical Chemistry"
}